Skip to main content
. Author manuscript; available in PMC: 2015 Dec 18.
Published in final edited form as: Cell. 2014 Dec 18;159(7):1591–1602. doi: 10.1016/j.cell.2014.11.020

Figure 4. ACSS2 Expression in Triple Negative Breast Cancers.

Figure 4

(A) Representative examples of high, medium, and low ACSS2 expression in triple negative breast cancers. The complete TMA staining is shown in Figure S3.

(B) High expression of ACSS2 was associated with poorer overall survival (p = 0.03).